Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing drug compliance using longitudinal marker data, with application to AIDS

H M Kim1, S W Lagakos

  • 1Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115.

Statistics in Medicine
|October 15, 1994
PubMed
Summary

Assessing medication adherence in clinical trials is crucial. New changepoint methods analyze longitudinal lab data to evaluate patient compliance, improving trial accuracy for self-administered drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicidal ideation trajectories among adults following psychiatric hospitalization.

Behaviour research and therapy·2026
Same author

Search for the K_{L}→π^{0}νν[over ¯] Decay at the J-PARC KOTO Experiment.

Physical review letters·2025
Same author

Do measures of social support and social distress share general factors associated with suicidal ideation and attempts?

Suicide & life-threatening behavior·2024
Same author

Depression symptom outcomes and re-engagement among VA patients who discontinue care while symptomatic.

General hospital psychiatry·2023
Same author

Search for the Pair Production of Dark Particles X with K_{L}^{0}→XX, X→γγ.

Physical review letters·2023
Same author

Study of the K_{L}→π^{0}νν[over ¯] Decay at the J-PARC KOTO Experiment.

Physical review letters·2021

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Pharmacometrics

Background:

  • Medication non-compliance in clinical trials for self-administered drugs poses significant challenges.
  • Traditional compliance assessment methods, such as self-reports and drug level assays, have notable limitations.

Purpose of the Study:

  • To adapt and extend changepoint methods for assessing medication compliance using longitudinal laboratory marker data.
  • To develop and examine maximum likelihood estimators for compliance assessment models.

Main Methods:

  • Utilized changepoint analysis on longitudinal laboratory marker data influenced by study medication.
  • Developed and evaluated maximum likelihood estimators for two compliance assessment models.
  • Investigated the impact of drug effects and observation timing on parameter estimability.

Related Experiment Videos

Main Results:

  • Maximum likelihood methods demonstrated good performance in most scenarios for compliance assessment.
  • Model parameter estimability depends on the drug's effect on the marker and observation timing relative to non-compliance.
  • Distinguishing compliance from non-compliance is unreliable when non-compliance occurs just before the final observation.

Conclusions:

  • Changepoint methods offer a viable approach to assess medication compliance from longitudinal marker data in clinical trials.
  • The effectiveness of these methods is influenced by specific study design factors.
  • Limitations exist, particularly when non-compliance is detected late in the study period.